Fate Therapeutics Inc (FATE)
4.22
+0.16
(+3.94%)
USD |
NASDAQ |
May 06, 16:00
4.22
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics 1 Year Total Returns (Daily): -35.76% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | -35.76% |
| May 02, 2024 | -30.74% |
| May 01, 2024 | -35.69% |
| April 30, 2024 | -34.93% |
| April 29, 2024 | -33.44% |
| April 26, 2024 | -34.71% |
| April 25, 2024 | -35.82% |
| April 24, 2024 | -32.18% |
| April 23, 2024 | -27.01% |
| April 22, 2024 | -23.15% |
| April 19, 2024 | -24.69% |
| April 18, 2024 | -19.10% |
| April 17, 2024 | -20.03% |
| April 16, 2024 | -10.48% |
| April 15, 2024 | -6.16% |
| April 12, 2024 | 2.85% |
| April 11, 2024 | 5.50% |
| April 10, 2024 | 14.42% |
| April 09, 2024 | 15.56% |
| April 08, 2024 | 14.70% |
| April 05, 2024 | 25.82% |
| April 04, 2024 | 26.04% |
| April 03, 2024 | 20.65% |
| April 02, 2024 | 19.30% |
| April 01, 2024 | 24.21% |
| Date | Value |
|---|---|
| March 28, 2024 | 39.28% |
| March 27, 2024 | 33.94% |
| March 26, 2024 | 27.27% |
| March 25, 2024 | 27.46% |
| March 22, 2024 | 28.35% |
| March 21, 2024 | 37.08% |
| March 20, 2024 | 33.63% |
| March 19, 2024 | 26.35% |
| March 18, 2024 | 27.08% |
| March 15, 2024 | 34.71% |
| March 14, 2024 | 31.93% |
| March 13, 2024 | 41.74% |
| March 12, 2024 | 56.97% |
| March 11, 2024 | 61.68% |
| March 08, 2024 | 44.48% |
| March 07, 2024 | 47.01% |
| March 06, 2024 | 37.11% |
| March 05, 2024 | 13.42% |
| March 04, 2024 | 15.88% |
| March 01, 2024 | 27.09% |
| February 29, 2024 | 15.85% |
| February 28, 2024 | 16.67% |
| February 27, 2024 | 24.13% |
| February 26, 2024 | 20.03% |
| February 23, 2024 | 14.10% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.61%
Minimum
Oct 04 2023
570.1%
Maximum
Dec 08 2020
30.84%
Average
12.73%
Median
1 Year Total Returns (Daily) Benchmarks
| Amicus Therapeutics Inc | -13.76% |
| Sarepta Therapeutics Inc | 6.56% |
| ADMA Biologics Inc | 95.69% |
| Ocular Therapeutix Inc | -0.32% |
| Viking Therapeutics Inc | 258.8% |